Close
Close
Treatment Database
humanized IgG4 kappa monoclonal antibody comprised of 2 identical light chains and 2 identical heavy chains fused to attenuated interferon alpha 2b
Trade Name not avaiable
Orphan Indication Multiple Myeloma
USA Market Approval
USA Designation Date 28-02-2019
Sponsor Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
40 Landsdowne Street,
Cambridge, Massachusetts, 02139
More about Multiple myeloma
Free Newsletter
Related Videos